9-Pentofuranosyl-9H-purine-2,6-diamine(CAS: 2096-10-8)

9-Pentofuranosyl-9H-purine-2,6-diamine (CAS: 2096-10-8) is regulated under the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) as a hazardous substance. It is also subject to the European Union's Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) regulations. Additionally, the U.S. Food and Drug Administration (FDA) and Environmental Protection Agency (EPA) have specific guidelines for the handling, storage, and disposal of this compound.

Alternatives to 9-Pentofuranosyl-9H-purine-2,6-diamine (CAS: 2096-10-8) in synthesis include various purine derivatives and analogs. Common alternatives include hypoxanthine and adenine, which can be used as precursors or substitutes in the synthesis of similar purine-based compounds. These alternatives may offer different reactivity profiles and can be chosen based on specific chemical requirements.

The research trend for 9-Pentofuranosyl-9H-purine-2,6-diamine (CAS: 2096-10-8) is focused on its potential applications in medicinal chemistry and pharmacology. There is increasing interest in its use as a nucleoside analog for antiviral and anticancer therapies. Market trends indicate growing demand in the pharmaceutical industry, driven by ongoing research and development efforts. However, the market remains niche due to its specific biological activity.

Waste containing 9-Pentofuranosyl-9H-purine-2,6-diamine (CAS: 2096-10-8) should be collected and treated according to local and international regulations. It is crucial to neutralize any acidic or basic waste and ensure complete inactivation of the compound before disposal. Incineration is a common method for disposal, but professional waste disposal services are recommended to ensure compliance with environmental protection precautions. Always consult the Safety Data Sheet (SDS) for specific handling instructions.